UK government Archives -

As the world and the UK continues its march out of the pandemic’s shadow, the pharmaceutical and life

Do pharmaceutical businesses need to rethink what their graduate schemes offer?

https://pharmaphorum.com/views-and-analysis/do-pharmaceutical-businesses-need-to-rethink-what-their-graduate-schemes-offer/

The UK government used the Queen’s Speech to set out its ambition to make the country a leader

UK highlights life sciences’ key role in post-COVID recovery

https://pharmaphorum.com/news/uk-highlights-life-sciences-key-role-in-post-covid-recovery/

How has rare disease care changed over the last few years? And what might we expect from the

Building a better future for people with rare diseases in all four UK nations

https://pharmaphorum.com/views-analysis-patients/building-a-better-future-for-people-with-rare-diseases-in-all-four-uk-nations/

The UK government’s massive spending on the coronavirus pandemic response has been “rife with conflicts of interest”, says

Labour accuses government of cronyism in COVID-19 contracts

https://pharmaphorum.com/news/labour-accuses-government-of-cronyism-in-covid-19-contracts/

Who could influence the makeup of the new PPRS?

Hung parliament: who will pharma negotiate with on new PPRS?

https://pharmaphorum.com/views-and-analysis/hung-parliament-will-pharma-negotiate-new-pprs/

The aims and implications of the Health Service Medical Supplies (Costs) Act 2017.

New UK law to control generic drug prices – implications for pharma

https://pharmaphorum.com/views-and-analysis/uk-drug-pricing-legislation/

UK government